Mutated factor x polypeptides and uses thereof for the treatment of haemophilia
US-2020299666-A1 · Sep 24, 2020 · US
This page is not indexed by search engines while we improve data quality.
Patent family 52396632
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 52396632 |
| Family type | — |
| Earliest priority | Jan 7, 2015 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US2020299666A1 — Mutated factor x polypeptides and uses thereof for the treatment of haemophilia |
Representative publication
Best representative member for this family based on priority and filing country.
US2020299666A1 — Mutated factor x polypeptides and uses thereof for the treatment of haemophilia (published Sep 24, 2020)
Member publications
Related publications in this family.